This is a service of EIN News a digital news provider
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
Adalimumab News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
FORMATS: RSS | EMAIL

Latest Adalimumab News

Sort by: relevance (24 hours) relevance date
  • Eshoo bill huge boon for Silicon Valley biotech 6 Dec 2009 14:15 GMT
    ... The provision would grant "biologic" drugs, a new class of drugs based on ... beta-1a (Rebif), treats multiple sclerosis. $50,933* - Adalimumab (Humira), treats rheumatoid arthritis and Crohn's disease. ... (Cerezyme), treats Gaucher's disease. *Costs are for treatment of Crohn's disease and gastrointestinal stromal tumor. ...

  • Research and Markets: Foreign Subsidiaries and Operations Generated 57.5 Per Cent of Eisai's Sales in Fiscal 2009 (Compared to 52.6 Per Cent in Fiscal 2006) 2 Dec 2009 18:14 GMT
    ... two main business areas: Pharmaceuticals, including ethical drugs, OTC products and diagnostics; and Others, which ... its two core products: Aricept, for the treatment of Alzheimer's disease, and Aciphex/Pariet, a therapy ... -- Anti-Inflammatory -- Actonel (risedronate) -- Humira (adalimumab) -- Diagnostics -- Iomeron (iomeprol) -- Oncology ...

  • Biologics for Rheumatoid Arthritis Work, but Which Is Best? 28 Nov 2009 05:57 GMT
    ... joints. In recent years, biologic disease-modifying anti-rheumatic drugs (DMARDs) have been introduced that can help ... including the number of swollen joints. For adalimumab, etanercept and rituximab, an increase of at ... of the disease, as well as prior treatment with other drugs." ...

  • Allos Therapeutics granted U.S. patent for FOLOTYN 30 Nov 2009 15:15 GMT
    ... MAP Pharmaceuticals, Inc. announced today that it will present ... bill, combined wi... The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the ... and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patien... Folate and vitamin ...


1 - 4 / 4

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ADALIMUMAB NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

For which of the following topics do you have the biggest problem finding news on the Internet? (Nov. 27, 2009)














 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.